Nephro-protective effect of granulocyte colony-stimulating factor in streptozotocin induced diabetic rats

References

• Cho H, Thorvaldsen JL, Chu Q, Feng F, Birnbaum MJ (2001) Akt1/PKB alpha is required for normal growth, but dispensable for maintenance of glucose homeostasis in mice. J. Biol. Chem. 276: 38349–38352.
   PubMed Web of Science ®Google Scholar
• Demetri GD, Griffin JD (1991) Granulocyte colony-stimulating factor and its receptor. Blood 78: 2791–2808.
   PubMed Web of Science ®Google Scholar
• El Mesallamy HO, Ahmed HH, Bassyouni AA, Ahmed AS (2012) Clinical significance of inflammatory and fibrogenic cytokines in diabetic nephropathy. Clin. Biochem. 45: 646–650.
   Google Scholar
• Elmarakby AA, Faulkner J, Baban B, Sullivan JC (2012) Induction of hemeoxygenase-1 reduces renal oxidative stress and inflammation in diabetic spontaneously hypertensive rats. Int. J. Hypertens. 2012: 957235. doi: 10.1155/2012/957235. Epub 2012 Feb 26. PubMed PMID: 22518298.
   Google Scholar
• Elsharawy MA, Naim M, Greish S (2012) Human CD34 + stem cells promote healing of diabetic foot ulcers in rats. Interac. Cardiovasc. Thor. Surg. 14: 288–293.
   PubMed Web of Science ®Google Scholar
• Fang TC, Pang CY, Chiu SC, Ding DC, Tsai RK (2012) Renoprotective effect of human umbilical cord-derived mesenchymal stem cells in immunodeficient mice suffering from acute kidney injury. PLoS One 7: e46504. doi:10.1371/journal.pone.0046504. Epub 2012 Sep 27. PubMed PMID.
   PubMed Web of Science ®Google Scholar
• Frampton JE, Lee CR, Faulds D (1994) Filgrastim. A review of its pharmacological properties and therapeutic efficacy in neutropenia. Drugs 48: 731–760.
   PubMed Web of Science ®Google Scholar
• Garofalo RS, Orena SJ, Rafidi K, Torchia AJ, Stock JL, Hildebrandt AL, Coskran T, Black SC, Brees DJ, Wicks JR, McNeish JD, Coleman KG (2003) Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. J. Clin. Invest. 112: 197–208.
   PubMed Web of Science ®Google Scholar
• Gibson CL, Jones NC, Prior MJ, Bath PM, Murphy SP (2005) G-CSF suppresses edema formation and reduces interleukin-1 beta expression after cerebral ischemia in mice. J. Neuropathol. Exp. Neurol. 64: 763–769.
   PubMed Web of Science ®Google Scholar
• Glowinska-Olszewska B, Moniuszko M, Hryniewicz A, Jeznach M, Rusak M, Dabrowska M, Luczynski W, Bodzenta-Lukaszyk A, Bossowski A (2013) Relationship between circulating endothelial progenitor cells (EPCs) and endothelial dysfunction in children with type 1 diabetes—a novel paradigm of early atherosclerosis in high-risk young patients. Eur. J. Endocrinol. 168: 153–161.
   Google Scholar
• Görgen I, Hartung T, Leist M, Niehörster M, Tiegs G, Uhlig S, Weitzel F, Wendel A (1992) Granulocyte colony- stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha. J. Immunol. 149: 918–924.
   PubMed Web of Science ®Google Scholar
• Grossfeld GD, Wolf JS Jr, Litwan MS, Hricak H, Shuler CL, Agerter DC, Carool PR (2001) Asymptomatic microscopic hematuria in adults: summary of the AUA best practice policy recommendations. Am. Fam. Phys. 63: 1145–1154.
   PubMed Web of Science ®Google Scholar
• Hers I, Vincent EE, Tavaré JM (2011) Akt signalling in health and disease. Cell Signal. 23: 1515–1527.
   PubMed Web of Science ®Google Scholar
• Ichinose K, Kawasaki E, Eguchi K (2007) Recent advancement of understanding pathogenesis of type 1 diabetes and potential relevance to diabetic nephropathy. Am. J. Nephrol. 27: 554–564.
   Google Scholar
• Jung DS, Lee SH, Kwak SJ, Li JJ, Kim Do H, Nam BY, Kang HY, Chang TI, Park JT, Han SH, Yoo TH, Kang SW (2012) Apoptosis occurs differentially according to glomerular size in diabetic kidney disease. Nephrol. Dial. Transpl. 27: 259–266.
   PubMed Web of Science ®Google Scholar
• Kang HJ, Kim HS, Zhang SY, Park KW, Cho HJ, Koo BK, Kim YJ, Soo Lee D, Sohn DW, Han KS, Oh BH, Lee MM, Park YB (2004) Effects of intracoronary infusion of peripheral blood stemcells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 363: 751–756.
   PubMed Web of Science ®Google Scholar
• Kanwar YS, Wada J, Sun L, Xie P, Wallner EI, Chen S, Chugh S, Denesh FR (2008) Diabetic nephropathy: mechanisms of renal disease progression. Exp. Biol. Med. 233: 4–11.
   PubMed Web of Science ®Google Scholar
• Lim YH, Joe JH, Jang KS, Song YS, So BI, Fang CH, Shin J, Kim JH, Lim HK, Kim KS (2011) Effects of granulocyte-colony stimulating factor (G-CSF) on diabetic cardiomyopathy in Otsuka Long-Evans Tokushima fatty rats. Cardiovasc. Diabetol. 17: 10: 92. doi: 10.1186/1475-2840-10-92. PubMed PMID: 2199946.
   Google Scholar
• Majka M, Janowska-Wieczorek A, Ratajczak J, Ehrenman K, Pietrzkowski Z, Kowalska MA, Gewirtz AM, Emerson SG, Ratajczak MZ (2001) Numerous growth factors, cytokines, and chemokines aresecreted by human CD34 + cells, myeloblasts, erythroblastsand regulate normal hematopoiesis in an autocrine/paracrine manner. Blood 15: 3075–3085.
   Google Scholar
• Makino H, Kashihara N, Sugiyama H, Kanao K, Sekikawa T, Okamoto K, Maeshima Y, Ota Z, Nagai R (1996) Phenotypic modulation of the mesangium reflected by contractile proteins in diabetes. Diabetes 45: 488–495.
   Google Scholar
• Makino H, Okada S, Nagumo A, Sugisawa T, Miyamoto Y, Kishimoto I, Akie TK, Soma T, Taguchi A, Yoshimasa Y (2008) Pioglitazone treatment stimulates circulating CD34-positive cells in type 2 diabetes patients. Diabetes Res. Clin. Pract. 81: 327–330.
   Google Scholar
• Mauer SM, Steffes MW, Ellin EN, Sutherland DE, Brown DM, Goetz FC (1984). Structural-functional relationships in diabetic nephropathy. J. Clin. Invest. 74: 1143–1155.
   PubMed Web of Science ®Google Scholar
• Menon R, Mohd Noor FS, Draman CR, Seman MR, Ghani AS (2012) A retrospective review of diabetic nephropathy patients during referral to the sub-urban nephrology clinic. Saudi J. Kidney Dis. Transpl. 23: 1109–1114.
   Google Scholar
• Mensah-Brown EP, Obineche EN, Galadari S, Chandranath E, Shahin A, Ahmed I, Patel SM, Adem A (2005) Streptozotocin-induced diabetic nephropathy in rats: the role of inflammatory cytokines. Cytokine 31: 180–190.
   PubMed Web of Science ®Google Scholar
• Minatoguchi S, Takemura G, Chen XH, Wang N, Uno Y, Koda M, Arai M, Misao Y, Lu C, Suzuki K, Goto K, Komada A, Takahashi T, Kosai K, Fujiwara T, Fujiwara H (2004) Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment. Circulation 109: 2572–2580.
   PubMed Web of Science ®Google Scholar
• Modelli de Andrade LG, Viero RM, Cordeiro de Carvalho MF (2013) Treatment of adriamycin-induced nephropathy with erythropoietin and G-CSF. J. Nephrol. 26: 534–539.
   Google Scholar
• Nogueira BV, Palomino Z, Porto ML, Balarini CM, Pereira TM, Baldo MP, Casarini DE, Meyrelles SS, Vasquez EC (2012) Granulocyte colony stimulating factor prevents kidney infarction and attenuates renovascular hypertension. Cell Physiol. Biochem. 29: 143–152.
   Google Scholar
• Pagana KD, Pagana TJ (2002) Urine studies. In: Pagana KD, Pagana TJ, Eds., Mosby's Manual of Diagnostic and Laboratory Tests, 2nd ed., Mosby, St. Louis, MO. pp. 811–880.
   Google Scholar
• Pietrow PK, Karellas ME (2006) Medical management of common urinary calculi. Am. Fam. Phys. 74: 86–94.
   PubMed Web of Science ®Google Scholar
• Sato S, Kawamura H, Takemoto M, Maezawa Y, Fujimoto M, Shimoyama T, Koshizaka M, Tsurutani Y, Watanabe A, Ueda S, Halevi K, Saito Y, Yokote K (2009) Halofuginone prevents extracellular matrix deposition in diabetic nephropathy. Biochem. Biophys. Res. Commun. 379: 411–416.
   Google Scholar
• Schabitz WR, Kollmar R, Schwaninger M (2003) Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke 34: 745–751.
   PubMed Web of Science ®Google Scholar
• Schneider A, Krüger C, Steigleder T, Weber D, Pitzer C, Laage R, Aronowski J, Maurer MH, Gassler N, Mier W, Hasselblatt M, Kollmar R, Schwab S, Sommer C, Bach A, Kuhn HG, Schäbitz WR (2005) The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J. Clin. Invest. 115: 2083–2098.
   PubMed Web of Science ®Google Scholar
• Simerville JA, Maxted WC, Pahira JJ (2005) Urinalysis: a comprehensive review [published correction appears in Am. Fam. Phys. 71: 1153–1162.
   PubMed Web of Science ®Google Scholar
• Tejada T, Catanuto P, Ijaz A, Santos JV, Xia X, Sanchez P, Sanabria N, Lenz O, Elliot SJ, Fornoni A (2008) Failure to phosphorylate AKT in podocytes from mice with early diabetic nephropathy promotes cell death. Kidney Int. 73: 1385–1393.
   PubMed Web of Science ®Google Scholar
• Qi W, Chen X, Poronnik P, Pollock CA (2008) Transforming growth factor-β/connective tissue growth factor axis in the kidney. Int. J. Biochem. Cell Biol. 40: 9–13.
   Google Scholar
• Wolf G, Chen S, Ziyadeh FN (2005) From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes 54: 1626–1634.
   PubMed Web of Science ®Google Scholar
• Yeh ET, Zhang S, Wu HD, Körbling M, Willerson JT, Estrov Z (2003) Transdifferentiation of human peripheral blood CD34 + enriched cell population into cardiomyocytes,endothelial cells, and smooth muscle cells in vivo. Circulation 108: 2070–2073.
   PubMed Web of Science ®Google Scholar
• Zhao CT, Wang M, Siu CW, Hou YL, Wang T, Tse HF, Yiu KH (2012) Myocardial dysfunction in patients with type 2 diabetes mellitus: role of endothelial progenitor cells and oxidative stress. Cardiovasc. Diabetol. 11: 147. doi: 10.1186/1475-2840-11-147. PubMed PMID.
   Google Scholar
• Ziyadeh FN (2004) Mediators of diabetic renal disease: the case for TGF-B as the major mediator. J. Am. Soc. Nephrol. 15: 55–57.
   PubMed Web of Science ®Google Scholar